Harnessing the immune system to fight cancer, long a medical dream, is becoming a reality. Remarkable stories of tumors melting away and terminal illnesses going into remissions…— backed by solid data — have led to an explosion of interest and billions of dollars of investments in the rapidly growing field of immunotherapy.
All this has brought new optimism to cancer doctors — a sense that they have begun tapping into a force of nature, the medical equivalent of splitting the atom.
Hundreds of clinical trials involving immunotherapy…are underway for nearly every type of cancer. “People are asking, waiting, pleading to get into these trials,” said Dr. Arlene Siefker-Radtke[.]
If there is a potential downside to the advances, Dr. [Matthew] Hellmann said, it is that the buzz about immunotherapy has led some patients to think chemotherapy is passé.
“Immunotherapy represents a hugely important new tool, but chemotherapy can work too and has been the backbone of the way we’ve treated patients with…cancer,” he said. “Immunotherapy is not a replacement for that. It’s a new weapon.”
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Harnessing the Immune System to Fight Cancer